Copyright Reports & Markets. All rights reserved.

Global Parkinson’s Disease Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Parkinson’s Disease Treatment Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Oral
    • 1.4.3 Transdermal
    • 1.4.4 Subcutaneous
    • 1.4.5 Intestinal Infusion
  • 1.5 Market by Application
    • 1.5.1 Global Parkinson’s Disease Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacy
    • 1.5.3 Retail Pharmacy
    • 1.5.4 Online Pharmacy
  • 1.6 Coronavirus Disease 2019 (Covid-19): Parkinson’s Disease Treatment Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Parkinson’s Disease Treatment Industry
      • 1.6.1.1 Parkinson’s Disease Treatment Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Parkinson’s Disease Treatment Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Parkinson’s Disease Treatment Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Parkinson’s Disease Treatment Market Perspective (2015-2026)
  • 2.2 Parkinson’s Disease Treatment Growth Trends by Regions
    • 2.2.1 Parkinson’s Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Parkinson’s Disease Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Parkinson’s Disease Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Parkinson’s Disease Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Parkinson’s Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Parkinson’s Disease Treatment Players by Market Size
    • 3.1.1 Global Top Parkinson’s Disease Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Parkinson’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Parkinson’s Disease Treatment Market Concentration Ratio
    • 3.2.1 Global Parkinson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Treatment Revenue in 2019
  • 3.3 Parkinson’s Disease Treatment Key Players Head office and Area Served
  • 3.4 Key Players Parkinson’s Disease Treatment Product Solution and Service
  • 3.5 Date of Enter into Parkinson’s Disease Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Parkinson’s Disease Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Parkinson’s Disease Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global Parkinson’s Disease Treatment Market Size by Application (2015-2020)
  • 5.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Parkinson’s Disease Treatment Market Size (2015-2020)
  • 6.2 Parkinson’s Disease Treatment Key Players in North America (2019-2020)
  • 6.3 North America Parkinson’s Disease Treatment Market Size by Type (2015-2020)
  • 6.4 North America Parkinson’s Disease Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Parkinson’s Disease Treatment Market Size (2015-2020)
  • 7.2 Parkinson’s Disease Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Parkinson’s Disease Treatment Market Size by Type (2015-2020)
  • 7.4 Europe Parkinson’s Disease Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China Parkinson’s Disease Treatment Market Size (2015-2020)
  • 8.2 Parkinson’s Disease Treatment Key Players in China (2019-2020)
  • 8.3 China Parkinson’s Disease Treatment Market Size by Type (2015-2020)
  • 8.4 China Parkinson’s Disease Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Parkinson’s Disease Treatment Market Size (2015-2020)
  • 9.2 Parkinson’s Disease Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Parkinson’s Disease Treatment Market Size by Type (2015-2020)
  • 9.4 Japan Parkinson’s Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Parkinson’s Disease Treatment Market Size (2015-2020)
  • 10.2 Parkinson’s Disease Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Parkinson’s Disease Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Parkinson’s Disease Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Parkinson’s Disease Treatment Market Size (2015-2020)
  • 11.2 Parkinson’s Disease Treatment Key Players in India (2019-2020)
  • 11.3 India Parkinson’s Disease Treatment Market Size by Type (2015-2020)
  • 11.4 India Parkinson’s Disease Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Parkinson’s Disease Treatment Market Size (2015-2020)
  • 12.2 Parkinson’s Disease Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Parkinson’s Disease Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Parkinson’s Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Teva
    • 13.1.1 Teva Company Details
    • 13.1.2 Teva Business Overview and Its Total Revenue
    • 13.1.3 Teva Parkinson’s Disease Treatment Introduction
    • 13.1.4 Teva Revenue in Parkinson’s Disease Treatment Business (2015-2020))
    • 13.1.5 Teva Recent Development
  • 13.2 Roche
    • 13.2.1 Roche Company Details
    • 13.2.2 Roche Business Overview and Its Total Revenue
    • 13.2.3 Roche Parkinson’s Disease Treatment Introduction
    • 13.2.4 Roche Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 13.2.5 Roche Recent Development
  • 13.3 Prothena
    • 13.3.1 Prothena Company Details
    • 13.3.2 Prothena Business Overview and Its Total Revenue
    • 13.3.3 Prothena Parkinson’s Disease Treatment Introduction
    • 13.3.4 Prothena Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 13.3.5 Prothena Recent Development
  • 13.4 Acorda Therapeutics
    • 13.4.1 Acorda Therapeutics Company Details
    • 13.4.2 Acorda Therapeutics Business Overview and Its Total Revenue
    • 13.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Introduction
    • 13.4.4 Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 13.4.5 Acorda Therapeutics Recent Development
  • 13.5 Voyager Therapeutics
    • 13.5.1 Voyager Therapeutics Company Details
    • 13.5.2 Voyager Therapeutics Business Overview and Its Total Revenue
    • 13.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Introduction
    • 13.5.4 Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 13.5.5 Voyager Therapeutics Recent Development
  • 13.6 Impax Pharmaceuticals
    • 13.6.1 Impax Pharmaceuticals Company Details
    • 13.6.2 Impax Pharmaceuticals Business Overview and Its Total Revenue
    • 13.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Introduction
    • 13.6.4 Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 13.6.5 Impax Pharmaceuticals Recent Development
  • 13.7 UCB
    • 13.7.1 UCB Company Details
    • 13.7.2 UCB Business Overview and Its Total Revenue
    • 13.7.3 UCB Parkinson’s Disease Treatment Introduction
    • 13.7.4 UCB Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 13.7.5 UCB Recent Development
  • 13.8 AbbVie
    • 13.8.1 AbbVie Company Details
    • 13.8.2 AbbVie Business Overview and Its Total Revenue
    • 13.8.3 AbbVie Parkinson’s Disease Treatment Introduction
    • 13.8.4 AbbVie Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 13.8.5 AbbVie Recent Development
  • 13.9 MSD
    • 13.9.1 MSD Company Details
    • 13.9.2 MSD Business Overview and Its Total Revenue
    • 13.9.3 MSD Parkinson’s Disease Treatment Introduction
    • 13.9.4 MSD Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 13.9.5 MSD Recent Development
  • 13.10 Orion Pharmaceuticals
    • 13.10.1 Orion Pharmaceuticals Company Details
    • 13.10.2 Orion Pharmaceuticals Business Overview and Its Total Revenue
    • 13.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Introduction
    • 13.10.4 Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 13.10.5 Orion Pharmaceuticals Recent Development
  • 13.11 Intec Pharma
    • 10.11.1 Intec Pharma Company Details
    • 10.11.2 Intec Pharma Business Overview and Its Total Revenue
    • 10.11.3 Intec Pharma Parkinson’s Disease Treatment Introduction
    • 10.11.4 Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 10.11.5 Intec Pharma Recent Development
  • 13.12 NeuroDerm
    • 10.12.1 NeuroDerm Company Details
    • 10.12.2 NeuroDerm Business Overview and Its Total Revenue
    • 10.12.3 NeuroDerm Parkinson’s Disease Treatment Introduction
    • 10.12.4 NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 10.12.5 NeuroDerm Recent Development
  • 13.13 Adamas Therapeutics
    • 10.13.1 Adamas Therapeutics Company Details
    • 10.13.2 Adamas Therapeutics Business Overview and Its Total Revenue
    • 10.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Introduction
    • 10.13.4 Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 10.13.5 Adamas Therapeutics Recent Development
  • 13.14 Acadia
    • 10.14.1 Acadia Company Details
    • 10.14.2 Acadia Business Overview and Its Total Revenue
    • 10.14.3 Acadia Parkinson’s Disease Treatment Introduction
    • 10.14.4 Acadia Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 10.14.5 Acadia Recent Development
  • 13.15 Sunovion
    • 10.15.1 Sunovion Company Details
    • 10.15.2 Sunovion Business Overview and Its Total Revenue
    • 10.15.3 Sunovion Parkinson’s Disease Treatment Introduction
    • 10.15.4 Sunovion Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 10.15.5 Sunovion Recent Development
  • 13.16 GSK
    • 10.16.1 GSK Company Details
    • 10.16.2 GSK Business Overview and Its Total Revenue
    • 10.16.3 GSK Parkinson’s Disease Treatment Introduction
    • 10.16.4 GSK Revenue in Parkinson’s Disease Treatment Business (2015-2020)
    • 10.16.5 GSK Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Parkinson’s Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson’s Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Teva
    Roche
    Prothena
    Acorda Therapeutics
    Voyager Therapeutics
    Impax Pharmaceuticals
    UCB
    AbbVie
    MSD
    Orion Pharmaceuticals
    Intec Pharma
    NeuroDerm
    Adamas Therapeutics
    Acadia
    Sunovion
    GSK

    Market segment by Type, the product can be split into
    Oral
    Transdermal
    Subcutaneous
    Intestinal Infusion
    Market segment by Application, split into
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Parkinson’s Disease Treatment status, future forecast, growth opportunity, key market and key players.
    To present the Parkinson’s Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Parkinson’s Disease Treatment are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now